INCYTE CMO reports tax-withholding share disposition
INCYTE CORP chief medical officer Steven H. Stein reported an automatic share withholding to cover taxes tied to equity compensation.
Rhea-AI Filing Summary
INCYTE CORP chief medical officer Steven H. Stein reported an automatic share withholding to cover taxes tied to equity compensation. On this Form 4, 2,177 shares of common stock were withheld at an indicated value of $116.86 per share to satisfy tax withholding obligations when restricted stock units or earned performance shares settled.
After this tax-withholding disposition, Stein directly holds 76,150 shares of common stock. Footnote disclosure adds that his position also includes 73,591 shares of common stock underlying previously reported restricted stock units and earned performance shares that have not yet vested. This event reflects compensation-related tax treatment rather than an open-market sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 2,177 | $116.86 | $254K |
Footnotes (2)
- F1. Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
- F2. This includes an aggregate of 73,591 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
Key Figures
Key Terms
restricted stock units financial
tax withholding obligations financial
Form 4 regulatory
non-derivative financial
FAQ
What insider transaction did INCYTE CORP (INCY) report for Steven H. Stein?
Was Steven H. Stein’s INCYTE (INCY) Form 4 transaction an open-market sale?
What do the unvested equity awards for Steven H. Stein at INCYTE (INCY) include?
AI-generated analysis. How Rhea-AI works. Not financial advice.